CLINICAL USEFULNESS OF [(18)F] FLUORO-2-DEOXY-D-GLUCOSE UPTAKE IN 178 HEAD-AND-NECK CANCER PATIENTS WITH NODAL METASTASIS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY: CONSIDERATION OF ITS PROGNOSTIC VALUE AND ABILITY TO PROVIDE GUIDANCE FOR OPTIMAL SELECTION OF PATIENTS FOR PLANNED NECK DISSECTION

被引:30
作者
Inokuchi, Haruo [1 ]
Kodaira, Takeshi
Tachibana, Hiroyuki
Nakamura, Tatsuya [2 ]
Tomita, Natsuo
Nakahara, Rie
Takada, Akinori [2 ]
Mizoguchi, Nobutaka
Tamaki, Tsuneo [3 ]
Fuwa, Nobukazu [2 ]
机构
[1] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] So Tohoku Proton Ctr, Dept Radiat Oncol, Koriyama, Fukushima, Japan
[3] Nagoya PET Imaging Ctr, Dept Radiol, Aichi, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 79卷 / 03期
关键词
Head-and-neck cancer; Fluoro-2-deoxy-D-glucose; Positron emission tomography; FDG-PET; Prognosis; Chemoradiotherapy; Planned neck dissection; SQUAMOUS-CELL CARCINOMA; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; LOCALLY ADVANCED HEAD; FDG-PET; F-18; FLUORODEOXYGLUCOSE; RADIATION-THERAPY; LUNG-CANCER; PHASE-II; PREDICTION;
D O I
10.1016/j.ijrobp.2009.11.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the clinical effectiveness of pretreatment [(18)F] fluoro-2-deoxy-D-glucose-positron emission tomography for head-and-neck squamous cell carcinoma patients with nodal metastasis treated with chemoradiotherapy. Methods and Materials: Between March 2002 and December 2006, 178 patients with head-and-neck squamous cell carcinoma and nodal metastasis underwent fluoro-2-deoxy-D-glucose positron emission tomography before chemoradiotherapy. Fluoro-2-deoxy-D-glucose uptake by both the primary lesion and the neck node was measured using the standard uptake value (SUV). The overall survival, disease-free survival, local control, nodal progression-free survival, and distant metastasis-free survival rates were calculated, and several prognostic factors were evaluated. Results: The patients with a nodal SUV >= 6.00 had a significantly lower 3-year disease-free survival rate than those with a lower SUV (44% vs. 69%, p =.004). On multivariate analysis, a high SUV of nodal disease also proved to be a significantly unfavorable factor for disease-free survival (p =.04, 95% confidence interval [CI], 1.02-3.23), nodal progression-free survival (p =.05; 95% CI, 1.00-4.15), and distant metastasis-free survival (p =.016; 95% CI, 1.25-8.92). Among the patients with a greater nodal SUV (>= 6.00), those treated with planned neck dissection had better nodal progression-free survival than those in the observation group (p =.04, hazard ratio, 2.36; 95% CI, 1.00-5.85). Conclusion: Among head-and-neck squamous cell carcinoma patients treated with chemoradiotherapy, the pretreatment SUV of nodal disease was one of the strongest prognostic factors and also provided important information for the selection of patients suitable for planned neck dissection. (C) 2011 Elsevier Inc.
引用
收藏
页码:747 / 755
页数:9
相关论文
共 22 条
[11]   Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx [J].
Kim, Sang Yoon ;
Roh, Jong-Lyel ;
Kim, Mi Ra ;
Kim, Jae Seung ;
Choi, Seung-Ho ;
Nam, Soon Yuhl ;
Lee, Sang-Wook ;
Kim, Sung-Bae .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) :752-757
[12]   Prediction of prognosis using standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography for nasopharyngeal carcinomas [J].
Lee, Sang-wook ;
Nam, Soon Yuhl ;
Im, Ki Chun ;
Kim, Jae Seung ;
Choi, Eun Kyung ;
Ahn, Seung Do ;
Park, Sung Ho ;
Kim, Sang Yoon ;
Lee, Bong-Jae ;
Kim, Jong Hoon .
RADIOTHERAPY AND ONCOLOGY, 2008, 87 (02) :211-216
[13]   PRETREATMENT PRIMARY TUMOR SUVMAX MEASURED BY FDG-PET AND PATHOLOGIC TUMOR DEPTH PREDICT FOR POOR OUTCOMES IN PATIENTS WITH ORAL CAVITY SQUAMOUS CELL CARCINOMA AND PATHOLOGICALLY POSITIVE LYMPH NODES [J].
Liao, Chun-Ta ;
Chang, Joseph Tung-Chieh ;
Wang, Hung-Ming ;
Ng, Shu-Hang ;
Hsueh, Chuen ;
Lee, Li-Yu ;
Lin, Chih-Hung ;
Chen, I. -How ;
Huang, Shiang-Fu ;
Cheng, Ann-Joy ;
See, Lai-Chu ;
Yen, Tzu-Chen .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03) :764-771
[14]   Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? [J].
McHam, SA ;
Adelstein, DJ ;
Rybicki, LA ;
Lavertu, P ;
Esclamado, RM ;
Wood, BG ;
Strome, M ;
Carroll, MA .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (10) :791-798
[15]   Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data [J].
Pignon, JP ;
Bourhis, J ;
Domenge, C ;
Designé, L .
LANCET, 2000, 355 (9208) :949-955
[16]   Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer [J].
Posner, Marshall R. ;
Hershock, Diane M. ;
Blajman, Cesar R. ;
Mickiewicz, Elizabeth ;
Winquist, Eric ;
Gorbounova, Vera ;
Tjulandin, Sergei ;
Shin, Dong M. ;
Cullen, Kevin ;
Ervin, Thomas J. ;
Murphy, Barbara A. ;
Raez, Luis E. ;
Cohen, Roger B. ;
Spaulding, Monica ;
Tishler, Roy B. ;
Roth, Berta ;
del Carmen Viroglio, Rosana ;
Venkatesan, Varagur ;
Romanov, Ilya ;
Agarwala, Sanjiv ;
Harter, K. William ;
Dugan, Matthew ;
Cmelak, Anthony ;
Markoe, Arnold M. ;
Read, Paul W. ;
Steinbrenner, Lynn ;
Colevas, A. Dimitrios ;
Norris, Charles M., Jr. ;
Haddad, Robert I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17) :1705-1715
[17]   2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx [J].
Roh, J.-L. ;
Pae, K. H. ;
Choi, S.-H. ;
Kim, J. S. ;
Lee, S. ;
Kim, S.-B. ;
Nam, S. Y. ;
Kim, S. Y. .
EJSO, 2007, 33 (06) :790-795
[18]   [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer [J].
Sasaki, R ;
Komaki, R ;
Macapinlac, H ;
Erasmus, J ;
Allen, P ;
Forster, K ;
Putnam, JB ;
Herbst, RS ;
Moran, CA ;
Podoloff, DA ;
Roth, JA ;
Cox, JD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1136-1143
[19]   FDG-PET prediction of head and neck squamous cell cancer outcomes [J].
Schwartz, DL ;
Rajendran, J ;
Yueh, B ;
Coltrera, MD ;
LeBlanc, M ;
Eary, J ;
Krohn, K .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (12) :1361-1367
[20]   FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma [J].
Suzuki, Hidenori ;
Hasegawa, Yasuhisa ;
Terada, Akihiro ;
Hyodo, Ikuo ;
Nakashima, Tsutomu ;
Nishio, Masami ;
Tamaki, Tsuneo .
ORAL ONCOLOGY, 2009, 45 (07) :569-573